Biobank for Bipolar Disorder

Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder

The purpose of this study is to establish a bipolar disorder biobank with genetic data from 4000 people with Bipolar I Disorder (BDI), Bipolar II Disorder (BDII), and Schizoaffective Disorder, Bipolar Type (SA-BD) for use in genomic disease risk studies and pharmogenomic studies.

What will happen if I decide to participate?

The study includes a clinical interview and a blood draw. Participants will be compensated $50 for their time and contributions.

Study team

Principal Investigator (PI):
Study Coordinator:

Study status

Enrolling participants

Who can participate?

You may be eligible to participate in a University of Minnesota research study on the genetics of bipolar disorder if you:

  • Are between the ages of 18 and 80
  • Have been diagnosed with Bipolar I Disorder (BDI), or Bipolar II Disorder (BDII), or Schizoaffective Disorder, Bipolar Type (SA-BD) 

For more information:

Tegan Carr, study coordinator

or email: